恒瑞医药抗糖尿病药物专利布局分析

Analysis of the Distribution of Anti-diabetic Medicine in Hengrui Medicine

本文以恒瑞医药作为研究对象,通过收集、整理和分析其专利申请数据,重点关注抗糖尿病药物这一领域,从二肽基肽酶(DPPIV)抑制剂、钠依赖性葡糖转运蛋白(SGLT)抑制剂、G蛋白偶联受体激动剂、人胰岛素类似物方面入手,分析其专利技术的特点和现状,总结专利技术的发展脉络与布局情况,以期为后续企业申请人在研发方向、专利布局等方面提供参考。

This article takes Hengrui Medicine as the research object, collects, sorts and analyzes its patent application data, focusing on the field of anti-diabetic medicine, starting from the field of DPPIV inhibitors, SGLT inhibitors, G protein-coupled receptor agonists and human insulin analogs, and analyzing its patented technology. This paper analyzes its characteristics and current situation, summarizes the development of its patent technology and layout, and hopes to provide reference for the research and development direction and patent layout of other applicants.